CDER, CBER Post FY 2023 Employee Gains, But Behind User Fee Hiring Goals

The drug and biologics centers at the US Food and Drug Administration have grown nearly 7% and more than 4%, respectively, since the beginning of fiscal year 2023, a positive step as the FDA looks to better handle its growing workload.

But the agency remains behind several user fee program hiring goals, which may be difficult to make up, especially given the tight funding climate